Cite Filings / FDMT / 0001140361-24-019094

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

4D Molecular Therapeutics, Inc. Filed 2024-04-10 Acc 0001140361-24-019094

Documents 1

DEFA14A Proxy Materials , edge20023177x2_defa14a.htm

Around this filing

2025-04-29 DEFA14A Proxy Materials
2024-04-10 ARS Annual Report to Security Holders
2024-04-10 DEFA14A Proxy Materials
2024-04-10 DEF 14A Proxy Statement
2024-04-03 4 Chief Legal Officer sold 8,153 shares at $31.78 ($259,102)
2023-04-12 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading edge20023177x2_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…